390 related articles for article (PubMed ID: 26654747)
1. Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies.
Jang B; Kwon H; Katila P; Lee SJ; Lee H
Adv Drug Deliv Rev; 2016 Mar; 98():113-33. PubMed ID: 26654747
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of chemotherapeutics and proteins for synergistic therapy.
He C; Tang Z; Tian H; Chen X
Adv Drug Deliv Rev; 2016 Mar; 98():64-76. PubMed ID: 26546464
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
Hussain Z; Arooj M; Malik A; Hussain F; Safdar H; Khan S; Sohail M; Pandey M; Choudhury H; Ei Thu H
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1015-1024. PubMed ID: 29873531
[TBL] [Abstract][Full Text] [Related]
4. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
5. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
6. Polymer nanoparticulate drug delivery and combination cancer therapy.
Cao P; Bae Y
Future Oncol; 2012 Nov; 8(11):1471-80. PubMed ID: 23148619
[TBL] [Abstract][Full Text] [Related]
7. Drug Discovery and Development of Innovative Therapeutics--IBC's 13th Annual World Congress. Approaches to cancer therapy.
Napper A
IDrugs; 2008 Oct; 11(10):705-9. PubMed ID: 18828066
[No Abstract] [Full Text] [Related]
8. Near-infrared light-responsive nanomaterials for cancer theranostics.
Kim H; Chung K; Lee S; Kim DH; Lee H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment.
Cao J; Chen Z; Chi J; Sun Y; Sun Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):817-830. PubMed ID: 29405791
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
Parhi P; Mohanty C; Sahoo SK
Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
[TBL] [Abstract][Full Text] [Related]
12. Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.
Meng F; Han N; Yeo Y
Expert Opin Drug Deliv; 2017 Mar; 14(3):427-446. PubMed ID: 27476442
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers.
Dawar S; Singh N; Kanwar RK; Kennedy RL; Veedu RN; Zhou SF; Krishnakumar S; Hazra S; Sasidharan S; Duan W; Kanwar JR
Drug Discov Today; 2013 Dec; 18(23-24):1292-300. PubMed ID: 24055842
[TBL] [Abstract][Full Text] [Related]
14. Optimizing combination chemotherapy by controlling drug ratios.
Mayer LD; Janoff AS
Mol Interv; 2007 Aug; 7(4):216-23. PubMed ID: 17827442
[TBL] [Abstract][Full Text] [Related]
15. Hybrid nanoparticles for combination therapy of cancer.
He C; Lu J; Lin W
J Control Release; 2015 Dec; 219():224-236. PubMed ID: 26387745
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
Shen S; Liu M; Li T; Lin S; Mo R
Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
[TBL] [Abstract][Full Text] [Related]
17. Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.
Li Y; Thambi T; Lee DS
Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28941203
[TBL] [Abstract][Full Text] [Related]
18. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
Kemp JA; Shim MS; Heo CY; Kwon YJ
Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
[TBL] [Abstract][Full Text] [Related]
19. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
